Key Takeaways XRAY's Q3 revenues are estimated at $901.6M, with EPS expected at $0.45, showing muted top-line momentum.XRAY's OIS and CTS weakness likely offset steady EDS growth and stabilization in Wellspect Healthcare.Tariff pressures and soft U.S. demand may continue to weigh on XRAY's revenue and margin performance.DENTSPLY SIRONA Inc. (XRAY) is scheduled to release third-quarter 2025 results on Nov. 6, before the opening bell.In the last reported quarter, the company’s earnings beat the Zacks Consensu ...